Skip to main content
. 2016 Nov 7;7(49):81670–81679. doi: 10.18632/oncotarget.13164

Table 2. MiRNAs associated with prognosis in different clinical subclasses.

miRNA T1-2 HR(95%CI) T3-4 HR(95%CI) N0 HR(95%CI) N1-3 HR(95%CI) M0 HR(95%CI) M1 HR(95%CI)
miR-101-2 - - - 0.70(0.51-0.96) 0.81(0.68-0.98) -
miR-1269 - 0.90(0.82-0.98) - 0.93(0.87-0.99) - -
miR-138-1 - - 0.86(0.75-0.99) 1.20(1.02-1.40) - -
miR-139 1.28(1.08-1.51) - 1.25(1.03-1.51) -- 1.17(1.01-1.35) -
miR-144 - - 0.87(0.77-0.98) - 0.89(0.81-0.98) -
miR-182 0.82(0.71-0.96) - - 0.75(0.62-0.92) 0.85(0.74-0.97) -
miR-183 0.86(0.74-0.99) - - 0.77(0.62-0.94) - -
miR-190 0.82(0.70-0.97) 0.80(0.64-0.99) - 0.85(0.73-0.98) -
miR-195 - 0.58(0.38-0.87) - 0.73(0.56-0.97) - -
miR-326 1.13(1.02-1.26) - - 1.17(1.02-1.33) 1.13(1.03-1.25) -
miR-451 - - 0.87(0.77-0.98) - 0.91(0.83-0.99) -
miR-944 - - - 0.91(0.83-0.98) 0.93(0.88-0.99) -